Organ Transplant, Rejection Prophylaxis Medications
Drugs associated with Organ Transplant, Rejection Prophylaxis
The following drugs and medications are in some way related to, or used in the treatment of Organ Transplant, Rejection Prophylaxis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
See also...
Organ Transplant, Rejection Prophylaxis Medications in the Pipeline
- December 26, 2005 - NDA for Immunosuppressant FK506 Modified Release Formulation Submitted in the US
Latest Organ Transplant, Rejection Prophylaxis Blog Post
LifeCycle Pharma Announces Positive Interim Results of Phase 2 Clinical Trial of LCP-Tacro for the Prevention of Organ Rejection in De Novo Kidney Transplant Patients
Data confirms the once daily profile of LCP's extended release tablet formulation of tacrolimus when compared to twice daily Prograf® capsules (Astellas Pharma)
HØRSHOLM, Denmark--(BUSINESS WIRE)--Apr 30, 2009 - LifeCycle Pharma A/S (CSE:LCP), today...
View all Organ Transplant, Rejection Prophylaxis blog posts.
Organ Transplant, Rejection Prophylaxis Support Group Questions
Go to the Organ Transplant, Rejection Prophylaxis support group or view all Organ Transplant, Rejection Prophylaxis questions.
